{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:29Z","timestamp":1791299969223,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Germline mutations in <jats:italic>ATM<\/jats:italic> (encoding the DNA-damage signaling kinase, ataxia-telangiectasia-mutated) increase Familial Pancreatic Cancer (FPC) susceptibility, and <jats:italic>ATM<\/jats:italic> somatic mutations have been identified in resected human pancreatic tumors. Here we investigated how <jats:italic>Atm<\/jats:italic> contributes to pancreatic cancer by deleting this gene in a murine model of the disease expressing oncogenic Kras (Kras<jats:sup>G12D<\/jats:sup>). We show that partial or total ATM deficiency cooperates with Kras<jats:sup>G12D<\/jats:sup> to promote highly metastatic pancreatic cancer. We also reveal that ATM is activated in pancreatic precancerous lesions in the context of DNA damage and cell proliferation, and demonstrate that ATM deficiency leads to persistent DNA damage in both precancerous lesions and primary tumors. Using low passage cultures from primary tumors and liver metastases we show that ATM loss accelerates Kras-induced carcinogenesis without conferring a specific phenotype to pancreatic tumors or changing the status of the tumor suppressors p53, p16<jats:sup>Ink4a<\/jats:sup> and p19<jats:sup>Arf<\/jats:sup>. However, ATM deficiency markedly increases the proportion of chromosomal alterations in pancreatic primary tumors and liver metastases. More importantly, ATM deficiency also renders murine pancreatic tumors highly sensitive to radiation. These and other findings in our study conclusively establish that ATM activity poses a major barrier to oncogenic transformation in the pancreas via maintaining genomic stability.<\/jats:p>","DOI":"10.1038\/s41598-017-11661-8","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T13:38:14Z","timestamp":1504618694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer"],"prefix":"10.1038","volume":"7","author":[{"given":"Yiannis","family":"Drosos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yi","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Roys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold E.","family":"Rehg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa A.","family":"Begley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Sosa-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"11661_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.genom.4.070802.110341","volume":"4","author":"DE Hansel","year":"2003","unstructured":"Hansel, D. E., Kern, S. E. & Hruban, R. H. Molecular pathogenesis of pancreatic cancer. Annu Rev Genomics Hum Genet \n                           4, 237\u2013256, doi:https:\/\/doi.org\/10.1146\/annurev.genom.4.070802.110341 (2003).","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"11661_CR2","doi-asserted-by":"crossref","unstructured":"Bartsch, D. K., Gress, T. M. & Langer, P. Familial pancreatic cancer\u2013current knowledge. Nature reviews. Gastroenterology & hepatology \n                           9, 445\u2013453, doi:10.1038\/nrgastro.2012.111 (2012).","DOI":"10.1038\/nrgastro.2012.111"},{"key":"11661_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts, N. J. et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer discovery \n                           2, 41\u201346, doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0194 (2012).","journal-title":"Cancer discovery"},{"key":"11661_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Molecular cell \n                           40, 179\u2013204, doi:https:\/\/doi.org\/10.1016\/j.molcel.2010.09.019 (2010).","journal-title":"Molecular cell"},{"key":"11661_CR5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.1140735","volume":"319","author":"TD Halazonetis","year":"2008","unstructured":"Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science \n                           319, 1352\u20131355, doi:https:\/\/doi.org\/10.1126\/science.1140735 (2008).","journal-title":"Science"},{"key":"11661_CR6","doi-asserted-by":"crossref","unstructured":"Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity. Nature reviews. Cancer \n                           3, 155\u2013168, doi:10.1038\/nrc1011 (2003).","DOI":"10.1038\/nrc1011"},{"key":"11661_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-011811-132509","volume":"7","author":"PJ McKinnon","year":"2012","unstructured":"McKinnon, P. J. ATM and the molecular pathogenesis of ataxia telangiectasia. Annu Rev Pathol \n                           7, 303\u2013321, doi:https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132509 (2012).","journal-title":"Annu Rev Pathol"},{"key":"11661_CR8","doi-asserted-by":"crossref","unstructured":"Shiloh, Y. & Ziv, Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nature reviews. Molecular cell biology \n                           14, 197\u2013210, doi:10.1038\/nrm3546 (2013).","DOI":"10.1038\/nrm3546"},{"key":"11661_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi, M., Kipps, T. & Kurzrock, R. ATM Mutations in Cancer: Therapeutic Implications. Mol Cancer Ther \n                           15, 1781\u20131791, doi:https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0945 (2016).","journal-title":"Mol Cancer Ther"},{"key":"11661_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts, N. J. et al. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer discovery \n                           6, 166\u2013175, doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0402 (2016).","journal-title":"Cancer discovery"},{"key":"11661_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2014.11.042","volume":"148","author":"RC Grant","year":"2015","unstructured":"Grant, R. C. et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology \n                           148, 556\u2013564, doi:https:\/\/doi.org\/10.1053\/j.gastro.2014.11.042 (2015).","journal-title":"Gastroenterology"},{"key":"11661_CR12","doi-asserted-by":"crossref","unstructured":"Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature \n                           491, 399\u2013405, doi:10.1038\/nature11547 (2012).","DOI":"10.1038\/nature11547"},{"key":"11661_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell \n                           4, 437\u2013450, doi:https:\/\/doi.org\/10.1016\/S1535-6108(03)00309-X (2003).","journal-title":"Cancer Cell"},{"key":"11661_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neo.2016.02.002","volume":"18","author":"Y Drosos","year":"2016","unstructured":"Drosos, Y. et al. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation. Neoplasia \n                           18, 172\u2013184, doi:https:\/\/doi.org\/10.1016\/j.neo.2016.02.002 (2016).","journal-title":"Neoplasia"},{"key":"11661_CR15","doi-asserted-by":"crossref","unstructured":"Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature \n                           434, 907\u2013913, doi: http:\/\/www.nature.com\/nature\/journal\/v434\/n7035\/suppinfo\/nature03485_S1.html (2005).","DOI":"10.1038\/nature03485"},{"key":"11661_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.gastro.2004.03.058","volume":"127","author":"FS Schreiber","year":"2004","unstructured":"Schreiber, F. S. et al. Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology \n                           127, 250\u2013260, doi:https:\/\/doi.org\/10.1053\/j.gastro.2004.03.058 (2004).","journal-title":"Gastroenterology"},{"key":"11661_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell \n                           7, 469\u2013483, doi:https:\/\/doi.org\/10.1016\/j.ccr.2005.04.023 (2005).","journal-title":"Cancer Cell"},{"key":"11661_CR18","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1101\/gad.1475506","volume":"20","author":"H Ijichi","year":"2006","unstructured":"Ijichi, H. et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes & development \n                           20, 3147\u20133160, doi:https:\/\/doi.org\/10.1101\/gad.1475506 (2006).","journal-title":"Genes & development"},{"key":"11661_CR19","doi-asserted-by":"crossref","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature \n                           531, 47\u201352, doi:10.1038\/nature16965 (2016).","DOI":"10.1038\/nature16965"},{"key":"11661_CR20","doi-asserted-by":"crossref","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med \n                           17, 500\u2013503, doi:10.1038\/nm.2344 (2011).","DOI":"10.1038\/nm.2344"},{"key":"11661_CR21","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1073\/pnas.0601273103","volume":"103","author":"N Bardeesy","year":"2006","unstructured":"Bardeesy, N. et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci USA \n                           103, 5947\u20135952, doi:https:\/\/doi.org\/10.1073\/pnas.0601273103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"11661_CR22","doi-asserted-by":"crossref","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature \n                           518, 495\u2013501, doi:10.1038\/nature14169 (2015).","DOI":"10.1038\/nature14169"},{"key":"11661_CR23","doi-asserted-by":"crossref","unstructured":"Li, H. et al. The HINT1 tumor suppressor regulates both gamma-H2AX and ATM in response to DNA damage. J Cell Biol \n                           183, 253\u2013265, doi:10.1083\/jcb.200711150 (2008).","DOI":"10.1083\/jcb.200711150"},{"key":"11661_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2353\/ajpath.2007.061176","volume":"171","author":"L Zhu","year":"2007","unstructured":"Zhu, L., Shi, G., Schmidt, C. M., Hruban, R. H. & Konieczny, S. F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol \n                           171, 263\u2013273, doi:https:\/\/doi.org\/10.2353\/ajpath.2007.061176 (2007).","journal-title":"Am J Pathol"},{"key":"11661_CR25","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk, O. et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. The American journal of surgical pathology \n                           39, 1730\u20131741, doi:https:\/\/doi.org\/10.1097\/PAS.0000000000000533 (2015).","journal-title":"The American journal of surgical pathology"},{"key":"11661_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/dvdy.23740","volume":"241","author":"JJ Westmoreland","year":"2012","unstructured":"Westmoreland, J. J. et al. Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation. Dev Dyn \n                           241, 583\u2013594, doi:https:\/\/doi.org\/10.1002\/dvdy.23740 (2012).","journal-title":"Dev Dyn"},{"key":"11661_CR27","doi-asserted-by":"crossref","unstructured":"Koorstra, J. B. et al. Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. Mod Pathol \n                           22, 1439\u20131445, doi:10.1038\/modpathol.2009.114 (2009).","DOI":"10.1038\/modpathol.2009.114"},{"key":"11661_CR28","doi-asserted-by":"crossref","unstructured":"Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature \n                           444, 638\u2013642, doi:10.1038\/nature05327 (2006).","DOI":"10.1038\/nature05327"},{"key":"11661_CR29","doi-asserted-by":"crossref","unstructured":"Childs, B. G., Durik, M., Baker, D. J. & van Deursen, J. M. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med \n                           21, 1424\u20131435, doi:10.1038\/nm.4000 (2015).","DOI":"10.1038\/nm.4000"},{"key":"11661_CR30","doi-asserted-by":"crossref","unstructured":"Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature \n                           444, 633-637, doi:10.1038\/nature05268 (2006).","DOI":"10.1038\/nature05268"},{"key":"11661_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005475","volume":"4","author":"A Efeyan","year":"2009","unstructured":"Efeyan, A. et al. Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression. PLoS One \n                           4, e5475, doi:https:\/\/doi.org\/10.1371\/journal.pone.0005475 (2009).","journal-title":"PLoS One"},{"key":"11661_CR32","doi-asserted-by":"crossref","unstructured":"Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature \n                           436, 642\u2013642, doi:10.1038\/436642a (2005).","DOI":"10.1038\/436642a"},{"key":"11661_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell \n                           22, 737\u2013750, doi:https:\/\/doi.org\/10.1016\/j.ccr.2012.10.025 (2012).","journal-title":"Cancer Cell"},{"key":"11661_CR34","doi-asserted-by":"crossref","unstructured":"Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability\u2013an evolving hallmark of cancer. Nature reviews. Molecular cell biology \n                           11, 220\u2013228, doi:10.1038\/nrm2858 (2010).","DOI":"10.1038\/nrm2858"},{"key":"11661_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret, M. & Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu Rev Pathol \n                           10, 425\u2013448, doi:https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040424 (2015).","journal-title":"Annu Rev Pathol"},{"key":"11661_CR36","doi-asserted-by":"crossref","unstructured":"Russell, R. et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun \n                           6, 7677, doi:10.1038\/ncomms8677 (2015).","DOI":"10.1038\/ncomms8677"},{"key":"11661_CR37","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1182\/blood-2015-05-645424","volume":"126","author":"CJ Harbort","year":"2015","unstructured":"Harbort, C. J. et al. Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis. Blood \n                           126, 2842\u20132851, doi:https:\/\/doi.org\/10.1182\/blood-2015-05-645424 (2015).","journal-title":"Blood"},{"key":"11661_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-68","volume":"5","author":"S Rachagani","year":"2012","unstructured":"Rachagani, S. et al. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. J Hematol Oncol \n                           5, 68, doi:https:\/\/doi.org\/10.1186\/1756-8722-5-68 (2012).","journal-title":"J Hematol Oncol"},{"key":"11661_CR39","doi-asserted-by":"crossref","unstructured":"Shi, C. et al. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Lab Invest \n                           94, 409\u2013421, doi:10.1038\/labinvest.2014.10 (2014).","DOI":"10.1038\/labinvest.2014.10"},{"key":"11661_CR40","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1128\/MCB.01597-12","volume":"33","author":"A Shamma","year":"2013","unstructured":"Shamma, A. et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol Cell Biol \n                           33, 3113\u20133124, doi:https:\/\/doi.org\/10.1128\/MCB.01597-12 (2013).","journal-title":"Mol Cell Biol"},{"key":"11661_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ccr.2010.10.034","volume":"18","author":"M Squatrito","year":"2010","unstructured":"Squatrito, M. et al. Loss of ATM\/Chk2\/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell \n                           18, 619\u2013629, doi:https:\/\/doi.org\/10.1016\/j.ccr.2010.10.034 (2010).","journal-title":"Cancer Cell"},{"key":"11661_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-13-1239","volume":"20","author":"H Kim","year":"2014","unstructured":"Kim, H. et al. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res \n                           20, 1865\u20131872, doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1239 (2014).","journal-title":"Clin Cancer Res"},{"key":"11661_CR43","doi-asserted-by":"crossref","unstructured":"Hennig, J., McShane, M. P., Cordes, N. & Eke, I. APPL proteins modulate DNA repair and radiation survival of pancreatic carcinoma cells by regulating ATM. Cell Death Dis \n                           5, e1199, doi:10.1038\/cddis.2014.167 (2014).","DOI":"10.1038\/cddis.2014.167"},{"key":"11661_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/15384101.2017.1312236","volume":"16","author":"M Ayars","year":"2017","unstructured":"Ayars, M., Eshleman, J. & Goggins, M. Susceptibility of ATM-deficient pancreatic cancer cells to radiation. Cell Cycle \n                           16, 991\u2013998, doi:https:\/\/doi.org\/10.1080\/15384101.2017.1312236 (2017).","journal-title":"Cell Cycle"},{"key":"11661_CR45","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1158\/0008-5472.CAN-16-3398","volume":"77","author":"A Schmitt","year":"2017","unstructured":"Schmitt, A. et al. ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma. Cancer Res \n                           77, 3040\u20133056, doi:https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3398 (2017).","journal-title":"Cancer Res"},{"key":"11661_CR46","doi-asserted-by":"crossref","unstructured":"Knittel, G. et al. Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia. Nat Commun \n                           8, 153, doi:10.1038\/s41467-017-00210-6 (2017).","DOI":"10.1038\/s41467-017-00210-6"},{"key":"11661_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004901","volume":"11","author":"O Kiraly","year":"2015","unstructured":"Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S. & Engelward, B. P. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet \n                           11, e1004901, doi:https:\/\/doi.org\/10.1371\/journal.pgen.1004901 (2015).","journal-title":"PLoS Genet"},{"key":"11661_CR48","doi-asserted-by":"crossref","unstructured":"Lee, Y. et al. ATR maintains select progenitors during nervous system development. EMBO J \n                           31, 1177\u20131189, doi:10.1038\/emboj.2011.493 (2012).","DOI":"10.1038\/emboj.2011.493"},{"key":"11661_CR49","doi-asserted-by":"crossref","unstructured":"Kawaguchi, Y. et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nature genetics \n                           32, 128\u2013134, doi:10.1038\/ng959 (2002).","DOI":"10.1038\/ng959"},{"key":"11661_CR50","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA \n                           92, 9363\u20139367, doi:https:\/\/doi.org\/10.1073\/pnas.92.20.9363 (1995).","journal-title":"Proc Natl Acad Sci USA"},{"key":"11661_CR51","doi-asserted-by":"crossref","unstructured":"Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat Protoc \n                           1, 2315\u20132319, doi:10.1038\/nprot.2006.339 (2006).","DOI":"10.1038\/nprot.2006.339"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11661-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11661-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:40:23Z","timestamp":1671792023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11661-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11661"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11661-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"8 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11144"}}